An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma

Trial Overview

Am I Eligible?

Participating US Centers

The Ohio State University Comprehensive Cancer Center
The James Cancer Hospital and Solove Research Institute

This center has not yet started accepting patients.

Columbus, OH


Mayo Clinic

This center is currently accepting patients.

Rochester, MN


Memorial Sloan Kettering Cancer Center
Memorial Hospital

This center is currently accepting patients.

New York, NY


Dana-Farber Cancer Institute

This center is currently accepting patients.

Boston, MA


University of Kansas Cancer Center

This center is currently accepting patients.

Kansas City, KS


Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins Medicine

This center is currently accepting patients.

Baltimore, MD


Huntsman Cancer Institute
University of Utah

This center is currently accepting patients.

Salt Lake City, UT


Oregon Health and Science University (OHSU)
Knight Cancer Institute

This center is currently accepting patients.

Portland, OR


University of Colorado Cancer Center
Anschutz Cancer Pavilion

This center is currently accepting patients.

Aurora, CO


Beth Israel Deaconess Medical Center

This center has not yet started accepting patients.

Boston, MA


Indiana University Health

This center is currently accepting patients.

Indianapolis, IN


Cancer Institute of Florida

This center is currently accepting patients.

Orlando, FL


University of Tennessee Medical Center
Cancer Institute

This center has not yet started accepting patients.

Knoxville, TN


Intermountain Southwest Regional Cancer Clinic

This center has not yet started accepting patients.

St. George, UT


Nebraska Cancer Specialists (Omaha)

This center is currently accepting patients.

Omaha, NE


University of California San Francisco (Fresno Campus)

This center has not yet started accepting patients.

Fresno, CA

ACCEPTING

This trial is currently open and accepting patients.



Additional Information
Trial Phase

Phase 1/2

Trial Enrollment

60 sparks required

Trial Sponsors
  • Bristol-Myers Squibb
Trial Identifiers

Need Help?

(888) 828-2206

Weekdays 9am - 5pm EST

;